The therapeutic mechanism of mesenchymal stromal/stem cells (MSC) for the treatment of acute myocardial infarction is not well understood. Our goal was to get insights into this mechanism by analyzing the survival kinetics of allogeneic and syngeneic cell transplants under different tissue conditions. Two MSC cell banks, stably and equally expressing the luciferase reporter construct, were developed for these studies and injected directly to the myocardium of Lewis rat recipients under syngeneic or allogeneic transplantation conditions. Cell survival was monitored by real-time fashion for up to 2 weeks, using optical imaging device (IVIS, Xenogen Corp.). We found that both syngeneic and allogeneic grafts reduced significantly in size during the first week of transplantation, either in the normal or in the late infarcted heart (5 days after MI) and allotransplants became always smaller than syngeneic grafts during this period. Low dose of cyclosporine A treatment had a benefit on both allo-and syngeneic graft sizes, suggesting that multiple mechanisms play a role in early graft reduction. The MSC characteristic factors IL-6, IL-8, MCP-1, and VEGF were well above the control level in the heart tissue at 4 days after cell injection, suggesting that the peak therapeutic effect of MSC can be expected during the first week of the administration. Although allogeneic cells induced immunoglobulin production, their biological effects (cell survival, factor productions) are very similar to the syngeneic transplants and therefore they could deliver the same therapeutic effect as the syngeneic cells. Finally, freshly infarcted tissue (30 min) supported better the survival of MSC than late postischemic tissue (5 days) but only "off the shelf" allogeneic cell transplants fits with this treatment strategy.
INTRODUCTION
jected cells in the myocardium. Consequently, the transplantation conditions should have a strong impact on injected cell survival and may determine their life span in Multipotent mesenchymal stem/stromal cells (MSC) with potential capacity to differentiate into cardiomyo-the injured myocardium. Understanding the factors that affect tissue residence time may contribute to the devel-cytes and/or other cell lines have been applied in numerous preclinical studies (4,27, 30,36) and a recent clinical opment of more effective therapeutic strategies. Several laboratories have reported follow-up studies trial is testing their benefit for patients with acute MI (12). In most investigations, transplantation of MSC re-of transplanted MSC in the heart (1, 9, 16) . These investigations, however, characterized the transplanted cells sulted in improved cardiac function, but despite these encouraging data the mechanism of how the injected under a single condition and little information is available for a comparative analysis of graft survival under MSC lead to functional improvement of the infarcted heart is not well understood. It is reasonable to assume different circumstances. This occurs, at least partially, because the techniques used to monitor the fate of the that a positive correlation exists between the improved myocardial function and the residence time of the in-injected cells have significant limitations. For example, histological evaluations of cell engraftment using cells Isolation and Cultivation of Mesenchymal Stromal Cells labeled with BrdU, GFP (8, 19, 31, 34, 44) offer only an end of life data point for cell engraftment studies and Bone marrow samples of male Norway Brown and therefore cannot be employed for kinetics assessment of Lewis rats were harvested from the femurs and tibias of graft size in the same animal. Moreover, these methods multiple animals. Mononuclear fractions were isolated, also involve a tedious quantitative analysis. Application plated, and cultured according to a standard MSC cultiof radioisotopes for in vivo imaging (2,6) also has limivation protocol (11). tations because of the short biological and/or physical half-life of different radioligands and the nonspecific la-Vector Construction, Virus Preparation beling by secondary uptake of radioactive compounds.
The coding sequence of the firefly luciferase (Luc) To circumvent these difficulties, in the current study originating from pGL3 vector (Promega) was inserted we used in vivo biophotonic imaging technology (IVIS, into the BamH1 site of the replication incompetent re-Xenogen Corp.) that allows monitoring cell survival in combinant retrovirus vector pDON-AI (Takara Bio Inc). vivo within the living animal in a real-time fashion
The construct was further modified by replacing the 5′ (7,33). IVIS has already been applied for the spatial and LTR sequences with the EF1a promoter to increase lutemporal detection of cancer cells during drug and gene ciferase expression (50) . pDON-EF1aLuc.Neo vector therapy (13, 14, 24, 42, 48) to follow the survival and bio-( Fig. 1 ) was propagated in HEK293 cells, and the optidistribution of cell transplants (20, 21, 40, 47) or expresmal dilution of the unpurified culture supernatants was sion of viral genes (35). We further improved this techtitrated in pilot experiments on MSC. nique by combining it with retroviral overexpression of the firefly luciferase in the MSC to be injected. The ret-Preparation of Luc + /MSC L and Luc + /MCS NR Banks rovirus system offers stable integration of the target gene into the genome and therefore provides longer fol-Subconfluent Norway Brown and Lewis MSC were low-up periods than the adenoviruses. Additionally, this infected with the Luc + /retrovirus construct overnight. virus system allows the development of cell banks, pro-Positive cells were selected with 0.2 mg/ml neomycin viding uniform and highly comparable transplants for and propagated up to passage 10. The expanded neomydifferent studies. The bioluminescent signal released cin-resistant cells were then screened for luciferase acfrom the luciferin substrate after enzymatic cleavage by tivity and MSC surface marker expression before being the reporter enzyme is also preferred to a potentially apcryopreserved in small aliquots for further in vivo work. plicable fluorescent signal, because of its higher signal Luc + MSC from Lewis rats were called MSC L , and Luc + to background ratio (41) .
MSCs from Norway Brown rats were called MSC NB . Optical imaging of the heart in living animals by the biophotonic imaging method has been reported by Wu Preparation of Cells for Injection et al. (46) after injecting an adenovirus firefly lucerase Cryopreserved aliquots of MSC L and MSC NB banks reporter construct directly into the heart. The same were propagated in culture for 3-4 days. On the day of method was also utilized by Min and Bom for engraftinjection, cells were harvested by Accutase (Millipore), ment study of human MSC in the rat heart (25) after washed, counted, and aliquoted into 4 × 10 6 cells/80 µl being transduced by a luciferase adenovirus construct.
injection buffer for cell transplantation. The injection Our studies investigated MSC survival in a comprehenbuffer consisted of DMEM and 0.2% human serum alsive manner under different transplantation conditions bumin. The average viability of the different preps was and found short survival time for both allogeneic and >95%, as determined by propidium iodide staining. syngeneic transplants. Furthermore, quantitative differences between syngeneic and allogeneic transplant sizes Surgical Procedures were consistent during these studies but the tissue levels of MCP-1, IL-6, IL-8, and VEGF were very comparable All in vivo analyses were performed in adult, female Lewis rats (200-250 g). Rats received 44 mg/kg keta-after cell injection, suggesting a similar paracrine function of the two graft types in situ. mine, 5 mg/kg xylazine, and 1.5 mg/kg diazepin intraperitoneally for anesthesia and they were mechanically MATERIALS and METHODS ventilated during the surgery. The myocardial infarction was created by permanent ligation of the left anterior All experimental protocols were approved by the Institutional Animal Care and Use Committee of Genzyme descendent coronary artery via thoracotomy. Cell suspension or buffer was injected into four symmetrical lo-Corporation and conformed to the US National Institute of Health Guideline for the Care and Use of Laboratory cations of the left ventricle, corresponding to the infarct border zone. Animals. 
Assessment of Long-Term Transplant Survival
mals were removed from the follow-up studies. Typically each study group was represented by six animals. by CCD Camera/IVIS Animals received 300 mg/kg luciferin substrate by IP
Preparation of Heart Tissue Extracts and Cytokine injection. Image acquisition was performed on lightly
Quantitation by Linco Beadlyte anesthetized animals receiving inhaled isoflurane. Biolu-Animals were euthanized by pentobarbital overdose. minescence signals were collected by the IVIS 200 Im-
The hearts were removed quickly and washed with iceaging System (Xenogen Corp., Alameda, CA) equipped cold saline solution. The buffer or cell-injected area of with the standard CCD camera and the Living Image TM the left ventricle was quickly dissected out, transferred software, using bioluminescence mode of operation.
into protease inhibitors containing PBS, prepared ac-Bioluminescence light intensity was measured at the recording to the manufacturer (Protease Inhibitor Cocktail gion of interest and expressed in relative light units Tablet, Roche). Tissue pieces were then mechanically (RLU/min), as shown on one of the representative imhomogenized on ice by OMNI TH tissue homogenizer. ages (Fig. 2) . Serial images were collected from the Cell debris were separated by high speed centrifugation heart by the ventral/lateral oblique view for 40 min after (13,000 × g for 20 min at 4°C), the clear tissue supernaluciferin injection in 5-min intervals. Due to some diftants were transferred into clean tubes and stored at ferences in the luciferin absorption, the highest RLU/ −80°C until further testing. Cytokines/chemokines were min value of each animal was selected as the representaassayed by the premade rat 24 plex Linco beadlyte kit, tive data point for image analysis. We observed large according to the manufacturer and quantified by Lufluctuation in signal intensity at the very early postinjecminex 200. Protein concentrations of the same samples tion period; therefore, data acquisition for quantitative were also measured by Bradford assay for normalization analysis started 2-3 days after cell injection. Misdelivpurposes.
ery of cells into the LV cavity was verified by total body
Quantitative PCR screening shortly after injection. Bright signals in the brain and the kidney area were observed in these ani-Genomic DNA was isolated from heart samples by proteinase K digestion. The Y chromosome was quanti-mals, according to the arterial distribution. These ani- fied by sry gene-specific primers and probe as described the signal intensity (RLU/min) and the cell number in both MSC preparations and their dose-response curves previously (26) . In simultaneous experiments, the single copy gene osteopontin was also analyzed for normaliza-almost completely overlapped with each other (Fig. 3 ). Next, we investigated the effect of the reporter gene ex-tion.
pression on the character of cells by measuring the expression of MSC surface markers such as CD14, CD11b, Statistical Analysis CD29, CD31, CD45, CD73, CD90, MHC1 (RT1A), and The data are expressed as means ± SE. Statistical MHCII (RT1) through FACS analysis (not shown). The analysis was performed using Student's t-test and analylevel of these markers did not differ between Luc + and sis of covariance (ANCOVA). Multiple comparisons Luc − cells. were corrected for by using the Student-Newman-Keuls
To confirm the correlation between the in vivo signal test. A value of p < 0.05 was considered statistically sigintensity and cell number, heart samples from gendernificant.
mismatched male MSC transplants were assayed for Y chromosome copy number by quantitative PCR. We ob-RESULTS served that high signal intensity associated with high Y Characterization of Allo-and Syngeneic copy number while low signal intensity with low copy Luciferase-Positive MSC Banks for In Vivo Studies number of sry gene (Fig. 4) , indicating that light emission is proportional to the presence of the injected cells.
Reporter gene expression of the Luc + /MSC L and
In addition, when Luc + cells were killed by freeze and Luc + /MSC NB cell banks was compared in vitro by serial thaw cycles, bioluminescent signal was not detectable dilution of Luc + /MSC L and Luc + /MSC NB cells, measuring from these preparations either in vitro or in vivo after the luminescent light emission after substrate addition.
injecting the dead cells into animals (not shown), dem-In this analysis there was a linear relationship between onstrating that only viable cells can emit biolumines-types up to 9 days. At this time point the signal intensity became significantly higher in the syngeneic group (p < cence light.
These data together indicate that MSC L and MSC NB 0.01) and the transplant size stabilized for the rest of the study. In contrast, the allogeneic graft was barely were suitable for in vivo studies and that the bioluminescent signal intensity (RLU/min) represented the number detectable after 9 days and became undetectable after 14 days. of transplanted cells (graft size).
Survival of Allogeneic and Syngeneic Transplants Mild Immunosuppression Enhanced Transplant Survival in the Normal Heart
First, we investigated whether autologous (synge-Next we evaluated the effect of mild immunosuppression on the survival of newly transplanted syngeneic and neic) cell therapy has any benefit over allotransplantation by comparing cell survival. To this end, the same allogeneic cells. Animals were treated with 10 mg/kg cyclosporine A for 5 consecutive days, starting 1 day number of Luc + /MSC NB or Luc + /MSC L were injected into the normal hearts of Lewis recipients. We found that 3 before cell injection. This treatment approximately doubled the size of both the allogeneic and syngeneic grafts, days after delivery, the bioluminescence light intensity of the allogeneic and syngeneic groups was similar (9.12 × compared with controls that did not receive cyclosporine A. The improvement in graft size was detectable as early 10 7 and 1.16 × 10 8 RLU/min, respectively) as shown by the first data points of the solid lines in Figure 5 . This as 3 days and stayed similar throughout the 14-day duration of the experiment (Fig. 5 , dashed lines). Cyclosporine was followed by a parallel decrease of both transplant MSC L (open symbol, continuous line) or MSC NB (filled symbol, continuous line) were injected into the myocardium of the healthy, noninfarcted animals and graft survival was monitored for up to 2 weeks (six animals in each group). Differences between allo-and syngeneic transplants became statistically significant by day 9 (*p < 0.01) and stayed significant by the end of the study (**p < 0.05). The 10 mg/kg cyclosporine A treatment started 1 day before cell injection and continued for 4 more consecutive days (dashed lines, six animals in each group). Syngeneic grafts sizes became significantly larger under cyclosporine treatment for the whole duration of the study compared to non-cyclosporine-treated syngeneic controls (+p < 0.05) or to the cyclosporine-treated animals, receiving allotransplantation (0p < 0.05). Cyclosporine administration also improved allotransplants survival. No differences were observed between allo-and syngeneic (without cyclosporine) graft sizes when animals received cyclosporine treatment.
A treatment resulted superior survival of syngeneic tion, the 30-min grafts were still three times larger than the grafts transplanted 5 days after the myocardial insult transplants at every time point of the study, compared to any other treatment groups. Allotransplant sizes were (compare 1.4 × 10 8 vs. 4.13 × 10 7 RLU/min, p < 0.02). This difference, however, disappeared by the end of the also significantly larger (p < 0.02) under cyclosporine A administration than without. With this dosing regime, second week when the emitted light of the two treatment groups were markedly decreased and did not differ sig-the survival curves of the cyclosporine-treated allogeneic and the untreated syngeneic groups became similar nificantly from each other. These data suggest that graft sizes vary by the postis-to each other even at the late posttransplantation time points (9 and 14 days). Cyclosporine A effect on both chemic treatment time and the conditions in the acute phase of ischemia (30 min) are more amenable for cell transplant types suggests that the protective effect of this drug is mediated not just by immunosuppression.
retention and/or survival than later postinfarction time point (5 days). Moreover, this effect was only temporary Both Allogeneic and Syngeneic Grafts Survived Better and did not result in long-term cell survival. in Normal Hearts Compared to Infarcted Hearts Intramyocardial MSC Injection Increased the Levels Infarcted tissue with the associated inflammatory reof MSC-Specific Cytokines in the Myocardium actions (mononuclear, neutrophil invasion, cytokine release, etc.) and the hypoxic conditions most likely pre-To search for evidence of in situ MSC activity, we prepared tissue extracts of heart samples after MSC in-sents a hostile environment for the fresh cell transplant. Therefore, we asked whether the MSC grafts are sensi-jection and assayed them for the presence of MCP-1, IL-2, IL-6, and VEGF. As observed with human MSC tive to these tissue conditions and whether the different transplant types are similarly affected by this environ- (22) , these cytokines were elevated in the culture supernatant from rat MSC. In this study, luciferase-negative ment. For this purpose, recipient animals received allogeneic or syngeneic cells 5 days after infarction. The 5-syngeneic or allogeneic cells were delivered into the normal, noninfarcted myocardium, while control hearts day postligation time point was selected because many cell therapy treatments are more feasible at a later time were treated only with injection buffer. Based on the survival curves ( Fig. 5) , heart samples point of the postischemic episode. Graft viability was monitored only for 1 week following the treatment be-were harvested 1, 4, or 7 days after injection. Then the anterior heart wall corresponding to the injected area cause the major effect of infarct on graft size was expected during the first postinjection week. Similar to was isolated and processed for protein extraction and analysis. The relative cytokine levels after normalization noninfarct conditions, we observed parallel decreases of allogeneic and syngeneic graft sizes by time ( Fig. 6 ), but to buffer control are shown on Table 1 . No significant differences from the controls were observed on the first the survival in the infarcted tissue was smaller for both graft types, comparing day 7 flux values between the day after injection in either cell types. At 4 days there was a general increase in the levels of all four cytokines infracted (allo = 6.35 × 10 6 RLU/min, syn = 2.52 × 10 7 RLU/min) and normal hearts (allo = 1.09 × 10 7 RLU/ with both allogeneic and syngeneic transplants. Some of them had statistically higher levels than the buffer con-min, syn = 3.55 × 10 7 RLU/min) ( Fig. 5) . Moreover, infarct environment better reduced allograft sizes than the trol (bold and italic in Table 1 ), but no significant differences were observed between heart samples treated by syngeneic ones, because the difference between alloand syngeneic transplants became significant by day 7 different cell types. By day 7, however, the levels of most of these cytokines returned close to the basal level. (p < 0.01), while in the normal heart only by day 9 (see Fig. 5 ).
These data suggest that during the first few days of transplantation both the syngeneic and allogeneic cells Shorter Postinfarction Time Promoted the Survival are functionally active and produce their characteristic of Transplanted Cells cytokines, although the secretion may initially be compromised by the delivery procedures. To further investigate the infarction effect on transplant survival, syngeneic MSC were also injected into Serum IgG Concentration Was Significantly the heart at the onset of the hypoxia (30 min after coro-Higher in the Allogeneic Than in the Syngeneic nary ligation) and transplant survival at two treatment Transplant Group points 5 days vs. 30 min were compared.
When cells were injected soon after coronary occlu-To investigate whether immune mechanisms played a role in reduced allograft survival, blood samples were sion (30 min), into the hypoxic tissue, graft sizes were significantly larger at most post-injection time points of collected from the same animals before cell injection and 2 weeks later. Two weeks following cell injections, the study, when compared to grafts injected 5 days after infarction (Fig. 7) . For example, 1 week after cell injec-animals that received allogeneic cells had IgG level transplant types further underlines the existence of such a mechanism. Thus, the anti-inflammatory effect of cyclosporine A could mitigate the nonspecific local in-(3143 ± 759 ng/ml) significantly higher (p < 0.02) than flammation, associated with the delivery procedure, the animals treated with syngeneic cells (1710 ± 491 ng/ sparing the transplant. Moreover, cyclosporine A has an ml) or their preimmune controls (1175 ± 231 ng/ml).
antiapoptotic effect, too, by blocking mitochondrial per-Moreover, cyclosporine A treatment of the allogeneic meability (37) , which is a critical mechanism of detachtransplant group reduced the serum IgG level to 1760 ± ment-associated cell death (38). Clinical application of 86 ng/ml. Smaller reduction in the syngeneic treatment cyclosporine A during acute myocardial infarction is not group (1601 ± 561 ng/ml) was also noticed. No differsuggested, but protection of the early transplant by tarence was detected in the serum IgM levels when assayed geting anchorage-dependent cell death (32) or improvsimultaneously (not shown).
ing the delivery technique (10,29) may enhance the per-These observations suggest that allogeneic MSC proformance of the transplant. voke an immune response in the recipient animals and Although MSC L and MSC NB graft sizes changed in that mild immunosuppression can blunt this response.
parallel with time, allografts were always significantly smaller than syngeneic grafts, suggesting that immune DISCUSSION mechanisms also play a role in cell survival. This obser-Utilizing bioluminescence imaging technique (IVIS), vation was further supported by elevated serum IgG levour study compares for the first time the in vivo survival els of animals receiving allogeneic cells. MSC have of syngeneic and allogeneic cell transplants in normal been reported as an immunoprivileged cell type (17, 18) , and infarcted myocardium in a real-time fashion. The allowing their therapeutic application across the allogefirst optical imaging of the heart was reported by injecneic barrier. While we did not observe major adverse tion of an adenovirus-expressing firefly luciferase into effect, our data strongly suggest that allogeneic MSC the myocardium (46) . Here we report the construction directly injected into the myocardium are not neutral for and application of a retrovirus-based reporter vector, the host immune system. Similar conclusions can be which allows long-term propagation of infected cells drawn from a rat spinal cord injury model, where the without losing their biomarker expression and therefore long-term immune suppression promoted the survival of offers opportunities for more comprehensive studies.
the allogeneic MSC (39,49). Typically we followed the fate of the transplants be-
The tissue environment at the late postischemic time tween 2 days and 2 weeks after their direct injection into point (5 days post-MI) resulted in reduced MSC L and the heart tissue. Earlier than 2 days the signal intensity MSC NB graft sizes. In contrast, in the early postischemic showed some fluctuations, probably because the high environment (30 min after ligation) comparably larger initial flux was above the linear range of the detection. graft sizes were observed, although this favorable effect From independent experiments utilizing neutron activawas transient and did not promote long term (>2 weeks) tion technique, we have reported that 85-90% of the survival. We suggest that local tissue edema, associated europium prelabeled cells leave the heart in 5 min after with the ligation procedure in the early infarct could pasinjection (45). Therefore, the IVIS analysis from 2 days sively increase the acute retention of the cells and may after injection describes the fate of this residual fraction, extend the effective period of cell therapy. In addition, tor to improved transplant survival. Our tissue analysis on characteristic MSC factors such as IL-2, IL-6, and REFERENCES MCP-1 suggests that the injected cells are functioning
